REPRODUCIBILITY OF THE DIAGNOSES OF ENDOMETRIAL HYPERPLASIA ACCORDING TO THE WHO CLASSIFICATION AND THE MODIFIED (BINARY) CLASSIFICATION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. to study of the reproducibility of the diagnoses of endometrial hyperplasia (EH) by the leading gynecological pathologists of Moscow on the basis of the WHO classification (2003) and the modified (binary) classification that proposes two types of EH instead of four ones. Materials and methods. The study included 60 histological endometrial scraping specimens with diagnosed different types of EH, low-grade adenocarcinoma of the endometrium and the corpus uteri mucosa at the stage of proliferation and secretion. Results. There was a coincidence of the WHO classification-based diagnoses among the pathologists when examining endometrial scrapes in 31 of the 60 women; the other cases showed a discrepancy in the diagnoses. The к index in the diagnosis of the intact and abnormally altered endometrium averaged 0.59 (0.91 to 0.61). With the binary system for the diagnoses of endometrial pathological changes being used, there was a coincidence in histological conclusions made by the pathologists in 48 (80%) cases. The к index in the diagnosis of low- and high-grade EH averaged 0.72 (0.68 to 0.74). Conclusion. When the binary system is applied, the reproducibility rate for the diagnoses of EH is higher than that when the WHO classification is used, which permits the authors to recommend the binary classification to improve the diagnosis of EH. The reproducibility of its diagnoses can be also enhanced using immunohistochemical markers, among which the tumor suppressor PTEN, the proliferative marker Ki-67, the apoptotic marker Bcl-2, as well as steroid hormone receptors, insulin-like growth factors, and their receptors are most important.

Full Text

Restricted Access

About the authors

N. I KONDRIKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

A. V ASATUROVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

O. A MOGIREVSKAYA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

I. V BARINOVA

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region

A. I ANDREYEV

Moscow Family Planning and Reproduction Center One

V. P NAZHIMOV

Russian Children's Republican Hospital

References

  1. Бантыш Б.Б. Выявление информативных визуальных факторов по изображениям с гистологических препаратов при железистой гиперплазии эндометрия // Вестн. новых мед. технологий. — 2006. — T. 8, № 4. - C. 122.
  2. Кондриков Н.И. Патология матки. — М.: Практическая медицина, 2008.
  3. Чепик О.Ф. Морфогенез гиперпластических процессов // Практич. онкол. — 2005. — Т. 5, № 1. — С. 9—15.
  4. Allison K.H., Tenpenny E., Reed S.D. et al. Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? // Appl. Immunohistochem. Mol. Morphol. — 2008. — Vol. 16, № 4. — P. 329—343.
  5. Bergeron C., Nogales F., Masserali M., et al. A Multicentric European Study Testing the Reproducibility of the WHO Classification of Endometrial Hyperplasia With a Proposal of a Simplified Working Classification for Biopsy and Curettage Specimens // Am. J. Surg. Pathol. — 1999. — Vol. 23. — P. 1102—1108.
  6. Dietel M. The histological diagnosis of endometrial hyperplasia Is there a need to simplify? // Virch. Arch. — 2001 — Vol.439. — P. 604—608.
  7. Horn L.-C. Schnurrbusch U., Bilek K. Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progesterone treatment // Int. J. Gynecol. Cancer. — 2004. — Vol. 14. — Р. 348—353.
  8. Kendall B.S., Ronnet B.M., Isacsons C. et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma // Am. J. Surg. Pathol. — 1998. — Vol. 22. — P. 1012—1019.
  9. Kurman R.S., Kaminski P.F., Norris H.S. The behavior of endometrial hyperplasia. A long-term study of „untreated” hyperplasia in 170 patients // Cancer. — 1985. — Vol. 56. — P. 403—412.
  10. Ørbo A., Moe B.T., Arnes M. et al. Prognostic Markers for Detection of Coexistent Carcinoma in High-risk Endometrial Hyperplasia. // Anticancer Res. — 2010. — Vol. 30, № 11. — P. 4649—4655.
  11. Lawrence I-Kuei Lin. A concordance correlation coefficient to evaluate reproducibility // Biometrics. — 1989. — Vol. 45. — P. 255—268.
  12. Mutter, G.L. Histopathology of genetically defined endometrial precancers // Int. J. Gynecol. Pathol. — 2000. — Vol. 19. — P. 301—309.
  13. Mutter G.L., Baak J.P., Crum C.P. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry // J. Pathol. — 2000. — Vol. 190. — P. 462— 469.
  14. Mutter G.L., Zaino R.J., Baak J.P. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia // Int. J. Gynecol. Pathol. — 2007. — Vol. 26, № 2. — P. 103—114.
  15. Narges I.-M., Yarmohammadi M., Ahmadi S.A. Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran // Diagn. Path. — 2009. — Vol. 4. — P. 4—10.
  16. Prat J. Histologic diagnosis of endometrial hyperplasia. // Virch. Arch. — 2002. — Vol. 441, № 3. — P. 306—307.
  17. Reed S.D., Newton K.N., Clinton W.L. et. al. Incidence of endometrial hyperplasia // Am. J. Obst. Gynecol. — 2009. — Vol. 200, № 6. — P. 678e1—678e6.
  18. Scully R.E., Bonfiglio T.A., Kurman R.J. et al. // WHO. Histological typing of female genital truct tumors. — 2 rd ed. — Berlin: Heidelberg, 1994.
  19. Sherman M.E., Ronnett B.M., Ioffe O.B. Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification // Int. J. Gynecol Pathol. — 2008. — Vol. 27. — P. 318—325.
  20. Silverberg S.G. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma // Mod. Pathol. — 2000. — Vol. 13. — P. 309—327.
  21. Skov B.G., Broholm. H., Engel U. et al. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia // Int. J. Gynecol. Pathol. — 1997. — Vol. 16. — P. 33—37.
  22. Suh K.-S., Insun K., Moon Hyang P. A multiinstitutional consensus study on the pathologic diagnosis of endometrial hyperplasia and carcinoma // Korean J. Pathol. — 2008. — Vol. 42. — P. 87—93.
  23. Takreem A., Nargis D., Sadia R. Incidence of endometrial hyperplasia in 100 cases presenting with polymenorrhagia/ menorrhagia in perimenupausal women // J. Ayub. Med. Coll. Abbottabad. — 2009. — Vol. 21, № 2. — P. 60—63.
  24. Terakawa N., Kigawa J., Taketani Y. The behavior of endometrial hyperplasia Study Group // J. Obstet. Gynaecol. Res. — 1997. — Vol.23, № 3. — P. 223—230.
  25. Zaino R. J., Kanderer J., Trimble C.L. et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study // Cancer. — 2006. — Vol. 106. — P. 804—811.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies